Ameriprise’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.25M | Sell |
|
|||||
|
2023
Q4 | $1.68M | Sell |
|
|||||
|
2023
Q3 | $2.62M | Hold |
|
|||||
|
2023
Q2 | $6.05M | Buy |
|
|||||
|
2023
Q1 | $7.2M | Buy |
|
|||||
|
2022
Q4 | $6.43M | Sell |
|
|||||
|
2022
Q3 | $60.8M | Buy |
|
|||||
|
2022
Q2 | $48.4M | Buy |
|
|||||
|
2022
Q1 | $62.2M | Buy |
|
|||||
|
2021
Q4 | $36.6M | Buy |
|
|||||
|
2021
Q3 | $39.5M | Buy |
|
|||||
|
2021
Q2 | $47M | Buy |
|
|||||
|
2021
Q1 | $39.4M | Buy |
|
|||||
|
2020
Q4 | $48.2M | Buy |
|
|||||
|
2020
Q3 | $11.3M | Buy |
|